Healthcare · Profile from Healthcare Research Companion
Envision Healthcare Corporation
The Nashville-based physician-staffing company that ran emergency departments, anesthesia, hospitalist, radiology and neonatology services for hundreds of US hospitals. It went from a Dallas emergency-physician group (EmCare, 1972) through four owners (Laidlaw, Onex, Clayton Dubilier & Rice, the public markets), a merger with surgery-center operator AmSurg (2016) and a ~$9.9bn KKR buyout (2018) to Chapter 11 in May 2023. Its story is the clearest case in US healthcare of a business whose margins depended on patients being unable to choose their doctor, and of what happens to a leveraged company when the law closes that gap.
At a glance
- Founded
- 1972, Dallas, Texas, as EmCare (emergency-physician contract management), founded by Dr. Leonard Riggs and colleagues (reported)
- Founders
- Leonard M. Riggs Jr., MD, emergency physician, and partners (verify full founding group)
- Headquarters
- Nashville, Tennessee (after the 2016 AmSurg merger); earlier Greenwood Village, Colorado (EMSC/Envision) and Dallas (EmCare)
- Ownership / structure
- Private. Owned by its former lenders since emerging from Chapter 11 in November 2023 (reported). Earlier: Laidlaw (1997–2005), Onex (2005–2011, public as EMSC from December 2005), CD&R (2011–2013, then public as Envision Healthcare Holdings, NYSE: EVHC, 2013–2016), Envision Healthcare Corp (NYSE: EVHC, 2016–2018), KKR (2018–2023)
- Leadership (2026)
- Jason Owen, President and CEO (effective 15 April 2024, after CFO Henry Howe served as interim CEO). Former CEOs: William Sanger (EMSC/Envision), Christopher Holden (AmSurg, then Envision December 2016–February 2020), Jim Rechtin (February 2020–December 2023, then Humana CEO)
- Segment
- Provider: hospital-based physician services (emergency medicine, hospital medicine, anesthesiology, radiology, neonatology, surgical services); formerly ambulance (AMR, sold 2017–18) and ambulatory surgery (AmSurg, separated 2023)
- Payer and patient
- Commercial insurers, Medicare, Medicaid and uninsured patients billed by the physician group; hospitals pay subsidies or management fees where professional revenue does not cover cost. Patients are mostly emergency and inpatient patients who did not choose the clinician
- Scale
- Peak ~25,000+ clinicians and ~$7.8bn revenue (2017, with AmSurg, continuing operations excluding AMR; 10-K); ~17,000+ clinicians after emergence (2023–24, reported)
- Capital / price
- EMSC IPO December 2005; CD&R buyout ~$3.2bn including debt (2011); Envision IPO ~$1bn (August 2013, reported); AmSurg merger ~$15bn combined enterprise value (2016); KKR take-private ~$9.9bn including debt (2018); Chapter 11 with ~$7.7bn of funded debt (May 2023); AmSurg sold to Ascension for ~$3.9bn (announced June 2025, completed 2026, reported)
- Signature moves (incl. failures)
- Laidlaw spin-out as EMSC (2005); CD&R buyout (2011); Envision IPO (2013); AmSurg merger and AMR sale (2016–18); surprise-billing exposure and UnitedHealthcare fight (2017–21); KKR LBO (2018); dark-money campaign and the No Surprises Act (2019–22); Chapter 11 and AmSurg split (2023)
8 strategic moves analysed
Each one gets a full strategy file in the companion: context, the decision, the financing, what happened, and the lesson.
2005
EMSC Spinout from Laidlaw
Divestiture (carve-out by a financial sponsor) / IPO
2011
CDR Buyout of EMSC
Acquisition (leveraged take-private)
2013
Envision IPO
IPO (sponsor-backed re-listing)
2016
AmSurg Merger
Merger (all-stock "merger of equals") / divestiture
2017
Surprise Billing Exposure and UHC Fight
Pricing / network strategy and payer dispute (exposed by research and press)
2018
KKR Take Private
Acquisition (leveraged buyout)
2019
Dark Money Campaign and No Surprises Act
Lobbying and advocacy campaign / regulatory change
2023
Chapter 11 and AmSurg Separation
Bankruptcy / restructuring / divestiture